LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.29 | 84.90 | 3128 | 7934 | 0.3942 | 0.7349 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.29 | 84.90 | 3203 | 7934 | 0.4037 | 0.7412 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.29 | 84.90 | 2925 | 7934 | 0.3686 | 0.7172 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.29 | 84.90 | 3052 | 7934 | 0.3847 | 0.7284 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.99 | 84.90 | 3276 | 8212 | 0.3989 | 0.7399 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.99 | 84.90 | 3355 | 8212 | 0.4085 | 0.7462 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.99 | 84.90 | 3070 | 8212 | 0.3738 | 0.7228 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.99 | 84.90 | 3199 | 8212 | 0.3895 | 0.7336 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.70 | 84.90 | 3358 | 8484 | 0.3958 | 0.7395 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.70 | 84.90 | 3445 | 8484 | 0.4061 | 0.7463 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.70 | 84.90 | 3221 | 8484 | 0.3796 | 0.7287 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 65.70 | 84.90 | 3305 | 8484 | 0.3895 | 0.7354 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.41 | 84.90 | 3470 | 8766 | 0.3958 | 0.7413 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.41 | 84.90 | 3571 | 8766 | 0.4074 | 0.7488 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.41 | 84.90 | 3307 | 8766 | 0.3772 | 0.7288 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 67.41 | 84.90 | 3427 | 8766 | 0.3909 | 0.7380 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.11 | 84.90 | 3619 | 8988 | 0.4027 | 0.7470 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.11 | 84.90 | 3736 | 8988 | 0.4157 | 0.7553 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.11 | 84.90 | 3415 | 8988 | 0.3800 | 0.7320 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 69.11 | 84.90 | 3552 | 8988 | 0.3952 | 0.7422 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.81 | 84.90 | 3699 | 9132 | 0.4051 | 0.7494 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.81 | 84.90 | 3878 | 9132 | 0.4247 | 0.7616 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.81 | 84.90 | 3586 | 9132 | 0.3927 | 0.7413 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 70.81 | 84.90 | 3693 | 9132 | 0.4044 | 0.7489 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 72.52 | 84.90 | 3930 | 9214 | 0.4265 | 0.7632 | MN20160318_Q02 | L07 |